Pfizer Inc.
As of Oct 23, 2026 close
- Market cap
- $171.14B
- P/E (TTM)
- 39.48
- Forward P/E
- 80.11
- Dividend yield
- 5.65%
- 52-week range
- $23.62$30.25
- Volume (live)
- -
- Avg. volume (3M)
- 30.76M
Pfizer (PFE) Stock Price & Financial Analysis
Pfizer Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $29.81 - $30.32 |
|---|---|
| 52-Week High | $30.25 |
| 52-Week Low | $23.62 |
| Open | $30.28 |
| Volume (last close) | 29.48M |
| Average Volume (3M) | 30.76M |
| Revenue (TTM) | 63.70B |
|---|---|
| Net Income (TTM) | 4.33B |
| Free Cash Flow (TTM) | 10.99B |
| EPS (TTM) | $0.76 |
| Profit Margin | 6.81% |
| Operating Margin | 25.08% |
| Return on Equity (ROE) | 5.09% |
| Debt to Equity | 0.74 |
| Annual Dividend | $1.72 |
|---|---|
| Dividend Yield | 5.65% |
| Payout Ratio | 200.00% |
| Next Dividend Ex-Date | Nov 6, 2026 |
| Market Cap | 171.14B |
|---|---|
| Shares Outstanding | 5.70B |
| P/E Ratio (TTM) | 39.48 |
| Forward P/E | 80.11 |
| Price to Sales (P/S) | 2.69 |
| Price to Book (P/B) | 2.01 |
| EV/EBITDA | 18.66 |
| 50-Day MA | $28.08 |
|---|---|
| 200-Day MA | $26.61 |
| 1-Year Change | +23.31% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Pfizer at a Glance
As of the Oct 23, 2026 close, Pfizer (PFE) has a market capitalization of $171.14B. The stock trades at 39.5× trailing earnings, 80.1× forward earnings and 2.7× sales. Over the trailing twelve months it earned $4.33B on revenue of $63.70B (a 6.8% profit margin) and generated $10.99B of free cash flow. Revenue fell 0.2% year over year.
As of its latest reported balance sheet, it holds $976.00M in cash and securities against $63.19B of debt, a net debt position of $62.22B.
Pfizer pays a quarterly dividend totaling $1.72 per share a year, a 5.65% yield at the Oct 23, 2026 close, with 16 consecutive years of dividend increases.
The share price is up 23.3% over the past year. At $30.03 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $23.62 to $30.25, above its 200-day moving average of $26.61.
Based on 29 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $29.32, 2.4% below the Oct 23, 2026 close.
Frequently Asked Questions About Pfizer
What is the current stock price for PFE?
As of the Oct 23, 2026 close, PFE stock trades at $30.03. The 52-week range is $23.62–$30.25, with a day range of $29.81–$30.32.
What is the P/E ratio for PFE?
As of the Oct 23, 2026 close, Pfizer's trailing twelve-month (TTM) P/E ratio is 39.5, meaning investors pay $39.5 for every $1 of annual earnings. The forward P/E is 80.1, reflecting analyst expectations for future earnings. Pfizer operates in the Healthcare sector.
Does PFE pay dividends?
Yes, Pfizer pays a 5.65% annual dividend yield as of the Oct 23, 2026 close ($1.72 per share a year). The trailing twelve-month payout ratio is 200.0%. The next ex-dividend date is November 6, 2026.
What do analysts recommend for PFE?
Based on ratings from 29 professional analysts over the last 90 days, the consensus for PFE is Hold. The average 12-month price target is $29.32, a 2.4% downside from the Oct 23, 2026 close of $30.03.
What is the market cap of PFE?
As of the Oct 23, 2026 close, Pfizer's market capitalization is $171.14B, classifying it as a large-cap company. Pfizer operates in the Healthcare sector within the Drug Manufacturers - General industry.